%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Alvaro J. Martínez-Valencia, Carlos Frisherald Daza-Rivera, Mariana Rosales-Chilama, Alexandra Cossio, Elkin J. Casadiego Rincón, Mayur M. Desai, Nancy Gore Saravia, María Adelaida Gómez
Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis
www.plosntds.org
www.plosntds.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0005713.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0005713.ref002)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0005713.ref003)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0005713.ref006)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0005713.ref007)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0005713.ref008)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0005713.ref009)>>
endobj
23 0 obj
<>/Border[0 0 0]/A 29 0 R>>
endobj
29 0 obj
<>
endobj
24 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
25 0 obj
<>/Border[0 0 0]/A 31 0 R>>
endobj
31 0 obj
<>
endobj
26 0 obj
<>/Border[0 0 0]/A 32 0 R>>
endobj
32 0 obj
<>
endobj
27 0 obj
<>/Border[0 0 0]/A 33 0 R>>
endobj
33 0 obj
<>
endobj
28 0 obj
<>/Border[0 0 0]/A 34 0 R>>
endobj
34 0 obj
<>
endobj
15 0 obj
[35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R]
endobj
35 0 obj
<>stream
q
0.955 g
0 w
199.9998 715.3999 m
575.9997 715.3999 l
575.9997 528.4003 l
199.9998 528.4003 l
f*
0.83 0.64 0.02 0 k
372.0756 432.1134 m
376.8378 432.1134 l
h
f*
381.3165 432.1134 m
386.0787 432.1134 l
h
f*
494.9858 406.148 m
499.748 406.148 l
h
f*
504.9071 406.148 m
509.6693 406.148 l
h
f*
549.5244 393.1087 m
554.2866 393.1087 l
h
f*
298.4315 341.1213 m
303.1937 341.1213 l
h
f*
307.6157 341.1213 m
312.378 341.1213 l
h
f*
0 g
1 j
1 J
11.9999 0 0 11.9999 209.9905 697.3795 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Author)Tj
3.137 0 Td
(summary)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 209.9905 679.4078 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Control)Tj
3.3618 0 Td
(of)Tj
1.0148 0 Td
(cutaneous)Tj
4.2746 0 Td
(leishmaniasis)Tj
5.5332 0 Td
(\(CL\))Tj
2.1033 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(Americas)Tj
4.0025 0 Td
(is)Tj
0.8504 0 Td
(dependent)Tj
4.4561 0 Td
(upon)Tj
2.3243 0 Td
(active)Tj
2.5172 0 Td
(case)Tj
-32.944 -1.2982 Td
(detection)Tj
3.9401 0 Td
(and)Tj
1.7291 0 Td
(treatment.)Tj
4.3597 0 Td
(The)Tj
1.7858 0 Td
(efficacy)Tj
3.2201 0 Td
(and)Tj
1.7291 0 Td
(effectiveness)Tj
5.2044 0 Td
(of)Tj
1.0148 0 Td
(therapeutic)Tj
4.7338 0 Td
(interventions)Tj
5.5389 0 Td
(is)Tj
-33.2558 -1.3039 Td
(based)Tj
2.4717 0 Td
(on)Tj
1.2756 0 Td
(clinical)Tj
3.0784 0 Td
(resolution)Tj
4.2747 0 Td
(of)Tj
1.0204 0 Td
(disease,)Tj
3.2428 0 Td
(not)Tj
1.5704 0 Td
(on)Tj
1.2756 0 Td
(parasitological)Tj
5.9981 0 Td
(clearance.)Tj
4.1725 0 Td
(The)Tj
1.7859 0 Td
(detection)Tj
3.9344 0 Td
(of)Tj
-34.1005 -1.2983 Td
(dermotropic)Tj
/F12 1 Tf
5.2553 0 Td
[()-3()2()-4()12()18()6()16()18()4()]TJ
/F7 1 Tf
4.7906 0 Td
(in)Tj
1.0318 0 Td
(tissues)Tj
2.8233 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(nasal)Tj
2.245 0 Td
(and)Tj
1.7291 0 Td
(conjunctival)Tj
5.1534 0 Td
(mucosa,)Tj
3.5206 0 Td
(blood)Tj
2.5115 0 Td
(and)Tj
-32.1333 -1.2983 Td
(healthy)Tj
3.135 0 Td
(skin)Tj
1.8936 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(absence)Tj
3.3392 0 Td
(of)Tj
1.0148 0 Td
(signs)Tj
2.2223 0 Td
(and)Tj
1.7292 0 Td
(symptoms)Tj
4.3596 0 Td
(of)Tj
1.0148 0 Td
(disease,)Tj
3.2428 0 Td
(suggests)Tj
3.4809 0 Td
(that)Tj
1.7802 0 Td
(despite)Tj
3.0387 0 Td
(clinical)Tj
-32.7569 -1.3039 Td
(resolution,)Tj
4.5013 0 Td
(parasites)Tj
3.6907 0 Td
(persist)Tj
2.8176 0 Td
(subclinically.)Tj
5.3972 0 Td
(We)Tj
1.61 0 Td
(examined)Tj
4.1329 0 Td
(clinical)Tj
3.0728 0 Td
(and)Tj
1.7291 0 Td
(parasitological)Tj
6.0037 0 Td
(factors)Tj
-32.9553 -1.2982 Td
(associated)Tj
4.2576 0 Td
(with)Tj
/F12 1 Tf
1.9955 0 Td
[()-3()2()-4()12()18()6()16()18()4()]TJ
/F7 1 Tf
4.7906 0 Td
(persistence)Tj
4.6374 0 Td
(after)Tj
2.0353 0 Td
(standard-of-care)Tj
6.8711 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(CL)Tj
1.4173 0 Td
(caused)Tj
2.9196 0 Td
(by)Tj
/F12 1 Tf
-34.0778 -1.2983 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F12 1 Tf
0.9751 0 Td
[( )53()4()16()18()18()4()]TJ
/F7 1 Tf
(.)Tj
3.668 0 Td
(We)Tj
1.61 0 Td
(found)Tj
2.6192 0 Td
(that)Tj
1.7802 0 Td
(a)Tj
0.6519 0 Td
(high)Tj
2.007 0 Td
(proportion)Tj
4.6317 0 Td
(of)Tj
1.0148 0 Td
(CL)Tj
1.423 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9955 0 Td
(therapeutically)Tj
6.1172 0 Td
(achieved)Tj
-31.8612 -1.3039 Td
(clinical)Tj
3.0784 0 Td
(resolution)Tj
4.2746 0 Td
(of)Tj
1.0148 0 Td
(CL)Tj
1.423 0 Td
(harbor)Tj
2.9366 0 Td
(viable)Tj
/F12 1 Tf
2.5569 0 Td
[()-3()2()-4()12()18()6()16()18()4()]TJ
/F7 1 Tf
(.)Tj
5.0116 0 Td
(A)Tj
0.9014 0 Td
(previous)Tj
3.651 0 Td
(episode)Tj
3.2485 0 Td
(of)Tj
1.0148 0 Td
(CL)Tj
1.423 0 Td
(was)Tj
1.6951 0 Td
(found)Tj
2.6192 0 Td
(to)Tj
-34.8489 -1.2983 Td
(be)Tj
1.1508 0 Td
(a)Tj
0.652 0 Td
(protective)Tj
4.2066 0 Td
(factor)Tj
2.5398 0 Td
(for)Tj
1.389 0 Td
(parasite)Tj
3.3278 0 Td
(persistence.)Tj
4.8642 0 Td
(Treated,)Tj
3.532 0 Td
(clinically)Tj
3.7757 0 Td
(cured)Tj
2.4945 0 Td
(CL)Tj
1.423 0 Td
(patients)Tj
3.3675 0 Td
(consti-)Tj
-32.7229 -1.2983 Td
(tute)Tj
1.7688 0 Td
(an)Tj
1.2018 0 Td
(important)Tj
4.2803 0 Td
(proportion)Tj
4.6318 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(persistently)Tj
4.7906 0 Td
(infected)Tj
3.4185 0 Td
(human)Tj
3.0784 0 Td
(population)Tj
4.5921 0 Td
(whose)Tj
2.7213 0 Td
(clinical)Tj
-32.156 -1.2982 Td
(and)Tj
1.7291 0 Td
(epidemiological)Tj
6.565 0 Td
(significance)Tj
4.9379 0 Td
(remains)Tj
3.4412 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(determined.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 476.2204 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 459.2125 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Over)Tj
2.2166 0 Td
(95%)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(clinical)Tj
3.0727 0 Td
(manifestations)Tj
6.0775 0 Td
(of)Tj
1.0147 0 Td
(human)Tj
3.0785 0 Td
(infections)Tj
4.1555 0 Td
(caused)Tj
2.914 0 Td
(by)Tj
/F12 1 Tf
1.1849 0 Td
[()-3()2()-4()12()18()6()16()18()4()]TJ
/F7 1 Tf
4.7848 0 Td
(species)Tj
2.9991 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
/F12 1 Tf
-35.4555 -1.3039 Td
[( )53()4()16()18()18()4()]TJ
/F7 1 Tf
3.4412 0 Td
(subgenus)Tj
3.9458 0 Td
(consist)Tj
2.982 0 Td
(of)Tj
1.0148 0 Td
(cutaneous)Tj
4.2746 0 Td
(lesions.)Tj
3.1578 0 Td
(Although)Tj
/F12 1 Tf
4.0025 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F12 1 Tf
0.9751 0 Td
[( )53()4()16()18()18()4()]TJ
/F7 1 Tf
3.4469 0 Td
(species)Tj
2.9934 0 Td
(are)Tj
1.4513 0 Td
(typically)Tj
3.5603 0 Td
(con-)Tj
-35.2457 -1.2982 Td
(sidered)Tj
3.118 0 Td
(dermotropic,)Tj
5.4822 0 Td
(infection)Tj
3.7927 0 Td
(is)Tj
0.8448 0 Td
(systemic)Tj
3.6283 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(2)Tj
0 g
(].)Tj
1.2586 0 Td
(The)Tj
1.7858 0 Td
(presence)Tj
3.7077 0 Td
(and)Tj
1.7348 0 Td
(viability)Tj
3.4129 0 Td
(of)Tj
1.0148 0 Td
(parasites)Tj
3.6907 0 Td
(in)Tj
-34.7355 -1.2983 Td
(lesion)Tj
2.5738 0 Td
(scars)Tj
2.1713 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0318 0 Td
(otherwise)Tj
4.0876 0 Td
(healthy)Tj
3.1294 0 Td
(tissues,)Tj
3.0444 0 Td
(including)Tj
4.0422 0 Td
(blood,)Tj
2.7439 0 Td
(skin,)Tj
2.1146 0 Td
(nasal)Tj
2.2451 0 Td
(and)Tj
1.7291 0 Td
(conjunctival)Tj
-30.6423 -1.2983 Td
(mucosa,)Tj
3.5149 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(documented)Tj
5.2497 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
2.0012 0 Td
(active)Tj
2.5172 0 Td
(cutaneous)Tj
4.2746 0 Td
(disease)Tj
3.016 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(])Tj
2.3698 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(individ-)Tj
-34.2933 -1.3039 Td
(uals)Tj
1.7858 0 Td
(with)Tj
2.0012 0 Td
(asymptomatic)Tj
5.8507 0 Td
(infection)Tj
3.7927 0 Td
(residing)Tj
3.4526 0 Td
(in)Tj
1.0375 0 Td
(endemic)Tj
3.651 0 Td
(areas)Tj
2.245 0 Td
(of)Tj
/F12 1 Tf
1.0148 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F12 1 Tf
0.9694 0 Td
[( )53()4()16()18()18()4()]TJ
/F7 1 Tf
3.4469 0 Td
(transmission)Tj
5.3632 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
-34.6108 -1.2982 Td
(The)Tj
1.7801 0 Td
(ability)Tj
2.6929 0 Td
(of)Tj
/F12 1 Tf
1.0148 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F12 1 Tf
0.9751 0 Td
[( )53()4()16()18()18()4()]TJ
/F7 1 Tf
3.4469 0 Td
(parasites)Tj
3.685 0 Td
(to)Tj
1.0262 0 Td
(colonize)Tj
3.5546 0 Td
(host)Tj
1.9162 0 Td
(tissues)Tj
2.8176 0 Td
(without)Tj
3.3335 0 Td
(causing)Tj
3.2428 0 Td
(signs)Tj
2.2224 0 Td
(or)Tj
1.0998 0 Td
(symptoms)Tj
-32.8079 -1.2983 Td
(of)Tj
1.0147 0 Td
(disease)Tj
3.0161 0 Td
(reflects)Tj
3.0557 0 Td
(a)Tj
0.652 0 Td
(host-pathogen)Tj
5.9867 0 Td
(relationship)Tj
4.989 0 Td
(that)Tj
1.7801 0 Td
(is)Tj
0.8447 0 Td
(permissive)Tj
4.4901 0 Td
(for)Tj
1.3833 0 Td
(microbial)Tj
4.0648 0 Td
(persistence.)Tj
-30.081 -1.3039 Td
(Loss)Tj
1.9899 0 Td
(of)Tj
1.0148 0 Td
(susceptibility)Tj
5.4368 0 Td
(for)Tj
1.389 0 Td
(meglumine)Tj
4.7621 0 Td
(antimoniate)Tj
5.0627 0 Td
(and)Tj
1.7348 0 Td
(miltefosine)Tj
4.6658 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(reported)Tj
3.6566 0 Td
(after)Tj
2.0353 0 Td
(a)Tj
-36.612 -1.2983 Td
(single)Tj
2.5284 0 Td
(treatment)Tj
4.1386 0 Td
(course)Tj
2.8346 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(9)Tj
0 g
(].)Tj
1.2642 0 Td
(Thus,)Tj
2.4718 0 Td
(subclinical)Tj
4.4731 0 Td
(persistence)Tj
4.6374 0 Td
(of)Tj
/F12 1 Tf
1.0148 0 Td
[()-3()2()-4()12()18()6()16()18()4()]TJ
/F7 1 Tf
4.7849 0 Td
(after)Tj
2.0352 0 Td
(chemothera-)Tj
-31.4416 -1.2983 Td
(peutic)Tj
2.6758 0 Td
(interventions)Tj
5.5389 0 Td
(could)Tj
2.4491 0 Td
(favor)Tj
2.2791 0 Td
(the)Tj
1.4683 0 Td
(development)Tj
5.4085 0 Td
(of)Tj
1.0148 0 Td
(acquired)Tj
3.702 0 Td
(drug)Tj
2.1146 0 Td
(resistance)Tj
4.1272 0 Td
(and)Tj
1.7348 0 Td
(selection)Tj
3.7191 0 Td
(of)Tj
-36.2322 -1.3039 Td
(non-susceptible)Tj
6.5309 0 Td
(parasite)Tj
3.3222 0 Td
(populations,)Tj
5.1817 0 Td
(risking)Tj
2.9934 0 Td
(the)Tj
1.4683 0 Td
(usefulness)Tj
4.2916 0 Td
(of)Tj
1.0148 0 Td
(available)Tj
3.6681 0 Td
(and)Tj
1.7291 0 Td
(potentially)Tj
4.4617 0 Td
(new)Tj
-34.6618 -1.2982 Td
(drugs.)Tj
1.1962 -1.2983 Td
(The)Tj
1.7858 0 Td
(systemic)Tj
3.6283 0 Td
(detection)Tj
3.9345 0 Td
(of)Tj
1.0148 0 Td
(subclinical)Tj
/F12 1 Tf
4.473 0 Td
[()-3()2()-4()12()18()6()16()18()4()]TJ
/F7 1 Tf
4.7905 0 Td
(infection)Tj
3.7928 0 Td
(after)Tj
2.0352 0 Td
(clinical)Tj
3.0728 0 Td
(resolution)Tj
4.2802 0 Td
(of)Tj
1.0148 0 Td
(dis-)Tj
-35.0189 -1.2983 Td
(ease)Tj
1.8595 0 Td
(whether)Tj
3.4752 0 Td
(therapeutically)Tj
6.1171 0 Td
(achieved)Tj
3.7021 0 Td
(or)Tj
1.0941 0 Td
(after)Tj
2.0353 0 Td
(self-resolution,)Tj
6.1738 0 Td
(together)Tj
3.5376 0 Td
(with)Tj
1.9956 0 Td
(persistent)Tj
4.0875 0 Td
(asymp-)Tj
-34.0778 -1.3039 Td
(tomatic)Tj
3.2654 0 Td
(infection,)Tj
4.0195 0 Td
(could)Tj
2.4492 0 Td
(reveal)Tj
2.5738 0 Td
(a)Tj
0.6576 0 Td
(previously)Tj
4.3484 0 Td
(unrecognized)Tj
5.6635 0 Td
(magnitude)Tj
4.5354 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(human)Tj
3.0784 0 Td
(population)Tj
-33.0744 -1.2982 Td
(harboring)Tj
4.2179 0 Td
(viable)Tj
2.5511 0 Td
(parasites.)Tj
3.9118 0 Td
(The)Tj
1.7858 0 Td
(clinical)Tj
3.0728 0 Td
(and)Tj
1.7348 0 Td
(epidemiological)Tj
6.5593 0 Td
(impact)Tj
2.982 0 Td
(of)Tj
1.0148 0 Td
(subclinical)Tj
4.4674 0 Td
(infection,)Tj
-32.2977 -1.2983 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(factors)Tj
2.9027 0 Td
(that)Tj
1.7801 0 Td
(underlie)Tj
3.5546 0 Td
(parasite)Tj
3.3279 0 Td
(persistence)Tj
4.6374 0 Td
(or)Tj
1.0999 0 Td
(elimination,)Tj
5.074 0 Td
(are)Tj
1.4456 0 Td
(unknown.)Tj
4.3087 0 Td
(In)Tj
1.1055 0 Td
(this)Tj
1.6781 0 Td
(study)Tj
-34.1119 -1.3039 Td
(we)Tj
1.3266 0 Td
(explored)Tj
3.702 0 Td
(clinical)Tj
3.0784 0 Td
(and)Tj
1.7291 0 Td
(parasitological)Tj
5.9981 0 Td
(factors)Tj
2.9026 0 Td
(associated)Tj
4.2577 0 Td
(with)Tj
/F12 1 Tf
1.9955 0 Td
[()-3()2()-4()12()18()6()16()18()4()]TJ
/F7 1 Tf
4.7905 0 Td
(persistence)Tj
4.6375 0 Td
(after)Tj
-34.418 -1.2983 Td
(standard-of-care)Tj
6.8711 0 Td
(treatment)Tj
4.1329 0 Td
(of)Tj
1.0148 0 Td
(cutaneous)Tj
4.2746 0 Td
(leishmaniasis)Tj
5.5332 0 Td
(\(CL\))Tj
2.1033 0 Td
(caused)Tj
2.9196 0 Td
(by)Tj
/F12 1 Tf
1.1792 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F12 1 Tf
0.9752 0 Td
[( )53()4()16()18()18()4()]TJ
/F7 1 Tf
(.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 170.022 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Methods)Tj
/F0 1 Tf
0 -1.5023 Td
(Ethics)Tj
2.9149 0 Td
(statement)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 134.9858 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(This)Tj
1.9785 0 Td
(study)Tj
2.3811 0 Td
(was)Tj
1.6951 0 Td
(approved)Tj
3.9628 0 Td
(and)Tj
1.7235 0 Td
(monitored)Tj
4.4844 0 Td
(by)Tj
1.1735 0 Td
(the)Tj
1.4627 0 Td
(Institutional)Tj
5.159 0 Td
(Review)Tj
3.0841 0 Td
(Board)Tj
2.6362 0 Td
(for)Tj
1.3776 0 Td
(Ethical)Tj
2.982 0 Td
(Conduct)Tj
-34.1005 -1.2982 Td
(of)Tj
1.0147 0 Td
(Research)Tj
3.8041 0 Td
(Involving)Tj
4.0535 0 Td
(Human)Tj
3.3165 0 Td
(Subjects)Tj
3.4923 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(Centro)Tj
3.0331 0 Td
(Internacional)Tj
5.6126 0 Td
(de)Tj
1.1735 0 Td
(Entrenamiento)Tj
6.2759 0 Td
(e)Tj
0.6406 0 Td
(Inves-)Tj
-34.8999 -1.2983 Td
(tigaciones)Tj
4.2122 0 Td
(Me)Tj
0 Tc
0.9184 0.0511 Td
()Tj
-0.004 Tc
0.3969 -0.0511 Td
(dicas)Tj
2.2337 0 Td
(\(CIDEIM\))Tj
4.4447 0 Td
(with)Tj
1.9955 0 Td
(approval)Tj
3.7021 0 Td
(code)Tj
2.1033 0 Td
(CIEIH)Tj
2.8969 0 Td
(1221,)Tj
2.3528 0 Td
(in)Tj
1.0318 0 Td
(accordance)Tj
4.7395 0 Td
(with)Tj
1.9956 0 Td
(national)Tj
-33.0234 -1.3039 Td
(and)Tj
1.7291 0 Td
(international)Tj
5.4141 0 Td
(guidelines.)Tj
4.5014 0 Td
(All)Tj
1.3946 0 Td
(individuals)Tj
4.6488 0 Td
(voluntarily)Tj
4.5808 0 Td
(participated)Tj
4.9946 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(study.)Tj
2.6192 0 Td
(Written)Tj
-32.3884 -1.2983 Td
(informed)Tj
3.9741 0 Td
(consent)Tj
3.3279 0 Td
(was)Tj
1.7007 0 Td
(obtained)Tj
3.7304 0 Td
(from)Tj
2.2053 0 Td
(each)Tj
2.0296 0 Td
(participant.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 183.2882 23.6976 re
W* n
q
183.2315 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 389.3102 745.7952 cm
BT
/F6 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Leishmani)Tj
4.4716 0 Td
(a)Tj
/F0 1 Tf
0.7654 0 Td
(persistenc)Tj
4.4717 0 Td
(e)Tj
0.7653 0 Td
(after)Tj
2.1898 0 Td
(treatment)Tj
4.3796 0 Td
(and)Tj
1.8567 0 Td
(cure)Tj
2.1331 0 Td
(of)Tj
1.0417 0 Td
(CL)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.5591 34.9228 m
317.7071 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00057)Tj
3.8197 0 Td
(13)Tj
0 g
2.0905 0 Td
(July)Tj
1.9701 0 Td
(13,)Tj
1.5804 0 Td
(2017)Tj
25.3773 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(15)Tj
ET
Q
q
0.83 0.64 0.02 0 k
1 j
1 J
0 w
59.1307 685.6441 m
150.0094 685.6441 l
h
f*
137.1969 663.6472 m
175.4079 663.6472 l
h
f*
36 652.6488 m
75.7417 652.6488 l
h
f*
163.4457 630.652 m
184.5354 630.652 l
h
f*
36 619.6535 m
85.7764 619.6535 l
h
f*
0 g
7.9999 0 0 7.9999 36 708.7181 cm
BT
/F9 1 Tf
1 TL
-0.025 Tc
0 0 Td
(Funding:)Tj
/F10 1 Tf
3.5716 0 Td
(This)Tj
1.7788 0 Td
(work)Tj
2.0622 0 Td
(was)Tj
1.7008 0 Td
(supported,)Tj
4.2166 0 Td
(in)Tj
0.8929 0 Td
(part,)Tj
1.8992 0 Td
(by)Tj
-16.1221 -1.3748 Td
(COLCIENCIA)Tj
4.7338 0 Td
(S)Tj
0.7441 0 Td
(Grant)Tj
2.2678 0 Td
(250-2010)Tj
3.841 0 Td
(Code)Tj
2.1118 0 Td
(2229-519-)Tj
-13.6985 -1.3748 Td
(28930)Tj
2.5866 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(http://ww)Tj
3.7772 0 Td
(w.colcienci)Tj
4.0748 0 Td
(as.gov.co/)Tj
0 g
(\),)Tj
4.5638 0 Td
(US)Tj
-15.0024 -1.3748 Td
(National)Tj
3.2386 0 Td
(Institutes)Tj
3.6425 0 Td
(of)Tj
0.9496 0 Td
(Health)Tj
2.5725 0 Td
(\(NIH\))Tj
2.2677 0 Td
(Grants)Tj
-12.6709 -1.3748 Td
(R01AI104823)Tj
5.3787 0 Td
(and)Tj
1.5874 0 Td
(R01AI09377)Tj
4.6772 0 Td
(5)Tj
0.6945 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(https://www)Tj
4.8402 0 Td
(.)Tj
-17.178 -1.3748 Td
(niaid.nih.g)Tj
3.8126 0 Td
(ov/)Tj
0 g
(\),)Tj
1.9063 0 Td
(and)Tj
1.5874 0 Td
(US)Tj
1.3323 0 Td
(NIH)Tj
1.6512 0 Td
(Internationa)Tj
4.4221 0 Td
(l)Tj
0.4181 0 Td
(Fogarty)Tj
-15.13 -1.3748 Td
(Center)Tj
2.622 0 Td
(Global)Tj
2.5654 0 Td
(Infectious)Tj
3.8622 0 Td
(Disease)Tj
3.1111 0 Td
(Researc)Tj
2.9976 0 Td
(h)Tj
0.6945 0 Td
(Training)Tj
-15.8528 -1.3748 Td
(Program,)Tj
3.7063 0 Td
(Award)Tj
2.5866 0 Td
(Number)Tj
3.2386 0 Td
(D43)Tj
1.7504 0 Td
(TW006589)Tj
4.3442 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(https://)Tj
-15.6261 -1.3749 Td
(www.fic.nih.)Tj
4.5992 0 Td
(gov/)Tj
0 g
(\).)Tj
2.374 0 Td
(AJM)Tj
1.9205 0 Td
(and)Tj
1.5945 0 Td
(CFD)Tj
1.7504 0 Td
(were)Tj
2.0126 0 Td
(supporte)Tj
3.2953 0 Td
(d)Tj
-17.5465 -1.3748 Td
(by)Tj
1.1126 0 Td
(the)Tj
1.3748 0 Td
(COLCIE)Tj
2.8346 0 Td
(NCIAS)Tj
2.6434 0 Td
(Young)Tj
2.6362 0 Td
(Investigator)Tj
4.3725 0 Td
(s)Tj
0.6449 0 Td
(and)Tj
-15.619 -1.3748 Td
(Innovators)Tj
4.1953 0 Td
(Program)Tj
3.4795 0 Td
(Contract)Tj
3.3591 0 Td
(Number)Tj
3.2315 0 Td
(0714-2013.)Tj
-14.2654 -1.3748 Td
(The)Tj
1.5874 0 Td
(content)Tj
2.9976 0 Td
(is)Tj
0.8292 0 Td
(solely)Tj
2.3457 0 Td
(the)Tj
1.3677 0 Td
(responsibilit)Tj
4.4929 0 Td
(y)Tj
0.6449 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
-15.215 -1.3748 Td
(authors)Tj
3.0472 0 Td
(and)Tj
1.5874 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4174 0 Td
(necessarily)Tj
4.337 0 Td
(represent)Tj
3.7276 0 Td
(the)Tj
-16.1292 -1.3748 Td
(official)Tj
2.6291 0 Td
(views)Tj
2.3173 0 Td
(of)Tj
0.9426 0 Td
(the)Tj
1.3748 0 Td
(National)Tj
3.2386 0 Td
(Institutes)Tj
3.6425 0 Td
(of)Tj
0.9497 0 Td
(Health.)Tj
-15.0946 -1.3748 Td
(The)Tj
1.5874 0 Td
(funders)Tj
3.0472 0 Td
(had)Tj
1.5874 0 Td
(no)Tj
1.1693 0 Td
(role)Tj
1.6158 0 Td
(in)Tj
0.8858 0 Td
(study)Tj
2.2607 0 Td
(design,)Tj
2.9055 0 Td
(data)Tj
-15.0591 -1.3749 Td
(collection)Tj
3.7417 0 Td
(and)Tj
1.5874 0 Td
(analysis)Tj
2.9623 0 Td
(,)Tj
0.4464 0 Td
(decision)Tj
3.2882 0 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1465 0 Td
(or)Tj
-16.1221 -1.3748 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
/F9 1 Tf
-6.7606 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(declare)Tj
2.8843 0 Td
(that)Tj
1.6229 0 Td
(they)Tj
-17.3269 -1.3748 Td
(have)Tj
1.9559 0 Td
(no)Tj
1.1693 0 Td
(conflicts)Tj
3.3307 0 Td
(of)Tj
0.9425 0 Td
(interest)Tj
2.9693 0 Td
(with)Tj
1.7859 0 Td
(the)Tj
1.3677 0 Td
(contents)Tj
3.4158 0 Td
(of)Tj
-16.9371 -1.3748 Td
(this)Tj
ET
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
BT
1.5661 -26.8726 Td
(article.)Tj
ET
Q
endstream
endobj
46 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 50 0 R/Contents 51 0 R/TrimBox[0 0 612 792]>>
endobj
49 0 obj
<>stream
xuu7apgiq
w"Ž@Kq0Nf}{^~?ΛwdZI' @A @A @A @A @A @A @A @A @A @җwC?wݟgv6A @A`F/ˡ=я~}r?E/'>yC^_~N痿~~{__jk+7>ԥs\"/|w]>wSM|fW<}x?ٜhDmo3? OxֳdӟmhK0 |q{ܣ(o1Ϩ<;4ZT@o~G=#P'??Ox+|#K-kb)NXBfws6~vaۢ_f: p';^ov74< 6ۮƔ@-עoV=yOX:w|/~F%Z1xǣÞ|_j[V,;N_M|eLsnJ僭ԧ6_NZ_>['?g5C&vfb#6wsEM@Y>tS/}钪g%?თ%pի^5y_[ãh'9IN}SpKeƳlo϶nt# ͼɋ ZڻI,g9nY¾Is o#G"@A lAZh}-J_:̶HgWҕ-0|py]-nq!]O[W-L3`Y8}gYԮ\ʵ}ِh55^nӜB.M&9qd-[T|v70ܼ.,%|0E"gA`@`I(>hbf iKw@>N{IT\d6l؊M~8
QoGl~fuD [b"Rkڢ#jU :e4x˔{M
CZ/O;qy[tc^^z%!zm]]ފVKۍZ/lK.hCUݒNH+^Tɵ Ҫ[/Kd?5jU44py5Mo+vKDZ]MVܷ?NV]7J
vumLK˨U6S`tA l!(t&[Lk\Z'h87xZ+l|_&(kfY(ʉl4[žUM'@z?|;[w|;Aq-=ַUk)ծ^y.Φ{7֣{G 3dV sX@4?+
DW*QgMnrrB?a[e/~ |zk^)Oy
:k|};!XǺPαoy[ܨɿ4h&S'u2u{ߝN`yonͣ~V_?K=Jҥ"[ʩ/nv9g?k8x Np־mb-[VPX)Pt^?yWiRI 44ĈЖ<f> xuq1UB%uAm,I%p;\io¯F:m6KT[/!j
^T=moB
]*ͺ.J >|3n2\|LQk*ӷQ6Hvyx P6^$FX_y6NQpU JuҪ~`>;6UO GкW!(yPh
./KK[+<[}.EIhF!A>6w4&gޠ[~僚 KMQ ?z;NjlECo}k?\A -Gh?n]җf~U9Luԯ])NwӝgpC=t(xsNv29}nq͌১?[K113XEi|UQ'=I[qs=R+Y>
͇a8zZiqc81JH$;0`G
'yZ~#1kɸ
p
9թNe]xv} 9S3lVzQ_^2ѢJ#^PKMb]!bf|ud>9پG)*4MWYg<p3((k /zы.{˞D'RSL*JҖ-{\DTd~{߫/ocح/$[w8F~oѺ-{~ڍg
N ==G.me5dhάyٹ.} T+m$wp!qիFs\yCP!
O|BWjن@9oGrw@ mo PijO<*цj@U=B7eк'=I~GҵH]Ҟ'"4j~d%.|O
;*0AYW54v[
_%r[+y9U
"|{>{z.wQ~ZN&|%wJ&GP@xsV#Q{]샔觗U4N
5ɵ0f35;*^Fi%8 d
qJ伉
`A }:Myw{;~e&e9%f'kff`ɰ$M{=}x2Lل!x|݃Iok(-8خp qVawJ
libESVfBQblc7Waekt8˴-rRel&̵W+b*sy(G_-Y;Y5(s>hsJ DְȹSg[Yֿ6˴(sNiw ksPل)cEcho>{p@IfNM,Bs
iz|3qZo=LM)! s)\^iU\SWQcXi^[Ka#)JfMooWt~Ee(~2Ӿ˕ @*AevQx1ZEW+]^z//bH0MxU3H%!Vͼ)+.:7bff^f@6Kф
Dfq/ι"Ir
zg6eRkQX'&i'<(42{cC3Y92,W-}FUJ9U2 n